Current Environment: Production

Medical Services

Specialties

Programs & Services

Professional History

Benjamin Goodlett, PhD, specializes in cognitive assessment and talk therapy to individuals affected by inborn errors of metabolism. He completed his PhD through Wayne State University and his postdoctoral fellowship at Boston Children’s Hospital. Dr. Goodlett’s research is focused on understanding the cognitive, emotional, and behavioral needs of people with inborn errors of metabolism and their families. He maintains involvement in a number of clinical trials.

Publications

  1. Implications of the choroid plexus in Niemann-Pick disease Type C neuropathogenesis. Brain Behav Immun. 2025 Feb; 124:376-384. View Abstract

  2. Characterization of central manifestations in patients with Niemann-Pick disease type C. Genet Med. 2024 03; 26(3):101053. View Abstract

  3. Case report: Chronic pain in a pediatric patient with late-onset pompe disease. Front Pain Res (Lausanne). 2023; 4:1244609. View Abstract

  4. The experience of living with Niemann-Pick type C: a patient and caregiver perspective. Orphanet J Rare Dis. 2023 05 20; 18(1):120. View Abstract

  5. Neuropsychological assessment of adults with phenylketonuria using the NIH toolbox. Mol Genet Metab. 2023 05; 139(1):107579. View Abstract

  6. Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Nat Metab. 2022 Sep; 4(9):1214. View Abstract

  7. Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2022 Jan 15; 20(1):3. View Abstract

  8. Targeting neurological abnormalities in lysosomal storage diseases. Trends Pharmacol Sci. 2022 06; 43(6):495-509. View Abstract

  9. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Nat Metab. 2021 08; 3(8):1125-1132. View Abstract

  10. A multidisciplinary assessment of pain in juvenile idiopathic arthritis. Semin Arthritis Rheum. 2021 08; 51(4):700-711. View Abstract

  11. First 1.5 years of pegvaliase clinic: Experiences and outcomes. Mol Genet Metab Rep. 2020 Sep; 24:100603. View Abstract

  12. Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease. N Engl J Med. 2019 10 24; 381(17):1644-1652. View Abstract

  13. Maternal Depressive Symptoms and At-Risk Young Children's Internalizing Problems: The Moderating Role of Mothers' Positivity. Merrill Palmer Q (Wayne State Univ Press). 2017 Jan; 63(1):77-104. View Abstract

  14. Temperament, personality, and quality of life in pediatric cancer patients. J Pediatr Psychol. 2014 May; 39(4):459-68. View Abstract

  15. Longitudinal prediction of disruptive behavior disorders in adolescent males from multiple risk domains. Child Psychiatry Hum Dev. 2013 Aug; 44(4):561-72. View Abstract

  16. An overview of the "Positive Action for Today's Health" (PATH) trial for increasing walking in low income, ethnic minority communities. Contemp Clin Trials. 2010 Nov; 31(6):624-33. View Abstract
BESbswy
BESbswy